New drugs cause fundamental shift in Europe’s drug market

The number, type and availability of new drugs in Europe continued to increase in 2012, according to a report released today by the EMCDDA and Europol. Driven by globalisation, technological advancement and the Internet, an open market for new drugs has now developed which presents significant challenges to public health, law enforcement and policymaking.